The genus Inula and their metabolites: From ethnopharmacological to medicinal uses
The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Seca, Ana M.L. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014transfer abstract |
|---|
| Schlagwörter: |
|---|
| Umfang: |
25 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Oocyte provision as a (quasi) social market: Insights from Spain - Degli Esposti, Sara ELSEVIER, 2019, an interdisciplinary journal devoted to bioscientific research on indigenous drugs : the official journal of the International Society of Ethnopharmacology, New York, NY [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:154 ; year:2014 ; number:2 ; day:11 ; month:06 ; pages:286-310 ; extent:25 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jep.2014.04.010 |
|---|
| Katalog-ID: |
ELV017565642 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV017565642 | ||
| 003 | DE-627 | ||
| 005 | 20230625122456.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jep.2014.04.010 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014013000001.pica |
| 035 | |a (DE-627)ELV017565642 | ||
| 035 | |a (ELSEVIER)S0378-8741(14)00285-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 |a 390 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 390 |q DE-600 |
| 082 | 0 | 4 | |a 300 |a 610 |q VZ |
| 084 | |a 44.06 |2 bkl | ||
| 100 | 1 | |a Seca, Ana M.L. |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The genus Inula and their metabolites: From ethnopharmacological to medicinal uses |
| 264 | 1 | |c 2014transfer abstract | |
| 300 | |a 25 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored. | ||
| 520 | |a The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored. | ||
| 650 | 7 | |a MDA-MB-435 |2 Elsevier | |
| 650 | 7 | |a JNK |2 Elsevier | |
| 650 | 7 | |a PMNs |2 Elsevier | |
| 650 | 7 | |a ICAM-1 |2 Elsevier | |
| 650 | 7 | |a AHR |2 Elsevier | |
| 650 | 7 | |a OPN |2 Elsevier | |
| 650 | 7 | |a NF-κB |2 Elsevier | |
| 650 | 7 | |a HSV-1 |2 Elsevier | |
| 650 | 7 | |a PI3K |2 Elsevier | |
| 650 | 7 | |a MRSA |2 Elsevier | |
| 650 | 7 | |a iNOS |2 Elsevier | |
| 650 | 7 | |a LTB4 |2 Elsevier | |
| 650 | 7 | |a MDCK |2 Elsevier | |
| 650 | 7 | |a c-FLIP |2 Elsevier | |
| 650 | 7 | |a ED50 |2 Elsevier | |
| 650 | 7 | |a Th2 |2 Elsevier | |
| 650 | 7 | |a QR |2 Elsevier | |
| 650 | 7 | |a L-NAME |2 Elsevier | |
| 650 | 7 | |a VSMCs |2 Elsevier | |
| 650 | 7 | |a HSP70 |2 Elsevier | |
| 650 | 7 | |a DPPH |2 Elsevier | |
| 650 | 7 | |a GMK |2 Elsevier | |
| 650 | 7 | |a MIC |2 Elsevier | |
| 650 | 7 | |a G2/M |2 Elsevier | |
| 650 | 7 | |a PLA2 |2 Elsevier | |
| 650 | 7 | |a SiHa |2 Elsevier | |
| 650 | 7 | |a SW620 |2 Elsevier | |
| 650 | 7 | |a GSTs |2 Elsevier | |
| 650 | 7 | |a IL-2 |2 Elsevier | |
| 650 | 7 | |a DOX |2 Elsevier | |
| 650 | 7 | |a HT-29 |2 Elsevier | |
| 650 | 7 | |a NCI |2 Elsevier | |
| 650 | 7 | |a Tyrp1 |2 Elsevier | |
| 650 | 7 | |a ROS |2 Elsevier | |
| 650 | 7 | |a AMPK |2 Elsevier | |
| 650 | 7 | |a HL-60 |2 Elsevier | |
| 650 | 7 | |a MMP-9 |2 Elsevier | |
| 650 | 7 | |a Bcl-2 |2 Elsevier | |
| 650 | 7 | |a HIV-1 |2 Elsevier | |
| 650 | 7 | |a RAW264 |2 Elsevier | |
| 650 | 7 | |a COX-2 |2 Elsevier | |
| 650 | 7 | |a TPA |2 Elsevier | |
| 650 | 7 | |a COX-1 |2 Elsevier | |
| 650 | 7 | |a SGC-7901 |2 Elsevier | |
| 650 | 7 | |a MCF-7 |2 Elsevier | |
| 650 | 7 | |a A-549 |2 Elsevier | |
| 650 | 7 | |a HCT-116 |2 Elsevier | |
| 650 | 7 | |a L929sA |2 Elsevier | |
| 650 | 7 | |a G1 |2 Elsevier | |
| 650 | 7 | |a IKKβ |2 Elsevier | |
| 650 | 7 | |a IC50 |2 Elsevier | |
| 650 | 7 | |a LPS |2 Elsevier | |
| 650 | 7 | |a MBC |2 Elsevier | |
| 650 | 7 | |a U937 |2 Elsevier | |
| 650 | 7 | |a HeLa |2 Elsevier | |
| 650 | 7 | |a MSSA |2 Elsevier | |
| 650 | 7 | |a CC50 |2 Elsevier | |
| 650 | 7 | |a Nrf2 |2 Elsevier | |
| 650 | 7 | |a KB |2 Elsevier | |
| 650 | 7 | |a L929 |2 Elsevier | |
| 650 | 7 | |a PPARγ2 |2 Elsevier | |
| 650 | 7 | |a Capan-2 |2 Elsevier | |
| 650 | 7 | |a LOVO |2 Elsevier | |
| 650 | 7 | |a HIV/AIDS |2 Elsevier | |
| 650 | 7 | |a PGE2 |2 Elsevier | |
| 650 | 7 | |a Vero |2 Elsevier | |
| 650 | 7 | |a p47phox |2 Elsevier | |
| 650 | 7 | |a PMA |2 Elsevier | |
| 650 | 7 | |a STAT1 |2 Elsevier | |
| 650 | 7 | |a ATPase |2 Elsevier | |
| 650 | 7 | |a B16 |2 Elsevier | |
| 650 | 7 | |a IKK |2 Elsevier | |
| 650 | 7 | |a SOD |2 Elsevier | |
| 650 | 7 | |a AKT |2 Elsevier | |
| 650 | 7 | |a L6 |2 Elsevier | |
| 650 | 7 | |a AGS |2 Elsevier | |
| 650 | 7 | |a COX |2 Elsevier | |
| 650 | 7 | |a PBMCs |2 Elsevier | |
| 650 | 7 | |a SK-28 |2 Elsevier | |
| 650 | 7 | |a TNFR1 |2 Elsevier | |
| 650 | 7 | |a VCAM-1 |2 Elsevier | |
| 650 | 7 | |a PAF |2 Elsevier | |
| 650 | 7 | |a TNF-α |2 Elsevier | |
| 650 | 7 | |a DNA |2 Elsevier | |
| 650 | 7 | |a PDGF |2 Elsevier | |
| 650 | 7 | |a SCF |2 Elsevier | |
| 650 | 7 | |a HepG-2 |2 Elsevier | |
| 650 | 7 | |a MGC-803 |2 Elsevier | |
| 650 | 7 | |a sPLA2 |2 Elsevier | |
| 650 | 7 | |a CVB3 |2 Elsevier | |
| 650 | 7 | |a PC-3 |2 Elsevier | |
| 650 | 7 | |a ABTS |2 Elsevier | |
| 700 | 1 | |a Grigore, Alice |4 oth | |
| 700 | 1 | |a Pinto, Diana C.G.A. |4 oth | |
| 700 | 1 | |a Silva, Artur M.S. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Degli Esposti, Sara ELSEVIER |t Oocyte provision as a (quasi) social market: Insights from Spain |d 2019 |d an interdisciplinary journal devoted to bioscientific research on indigenous drugs : the official journal of the International Society of Ethnopharmacology |g New York, NY [u.a.] |w (DE-627)ELV002571021 |
| 773 | 1 | 8 | |g volume:154 |g year:2014 |g number:2 |g day:11 |g month:06 |g pages:286-310 |g extent:25 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jep.2014.04.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.06 |j Medizinsoziologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 154 |j 2014 |e 2 |b 11 |c 0611 |h 286-310 |g 25 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
a m s am ams |
|---|---|
| matchkey_str |
secaanamlgrigorealicepintodianacgasilvaa:2014----:hgnsnladhimtbltsrmtnpamcl |
| hierarchy_sort_str |
2014transfer abstract |
| bklnumber |
44.06 |
| publishDate |
2014 |
| allfields |
10.1016/j.jep.2014.04.010 doi GBVA2014013000001.pica (DE-627)ELV017565642 (ELSEVIER)S0378-8741(14)00285-2 DE-627 ger DE-627 rakwb eng 610 390 610 DE-600 390 DE-600 300 610 VZ 44.06 bkl Seca, Ana M.L. verfasserin aut The genus Inula and their metabolites: From ethnopharmacological to medicinal uses 2014transfer abstract 25 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored. The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored. MDA-MB-435 Elsevier JNK Elsevier PMNs Elsevier ICAM-1 Elsevier AHR Elsevier OPN Elsevier NF-κB Elsevier HSV-1 Elsevier PI3K Elsevier MRSA Elsevier iNOS Elsevier LTB4 Elsevier MDCK Elsevier c-FLIP Elsevier ED50 Elsevier Th2 Elsevier QR Elsevier L-NAME Elsevier VSMCs Elsevier HSP70 Elsevier DPPH Elsevier GMK Elsevier MIC Elsevier G2/M Elsevier PLA2 Elsevier SiHa Elsevier SW620 Elsevier GSTs Elsevier IL-2 Elsevier DOX Elsevier HT-29 Elsevier NCI Elsevier Tyrp1 Elsevier ROS Elsevier AMPK Elsevier HL-60 Elsevier MMP-9 Elsevier Bcl-2 Elsevier HIV-1 Elsevier RAW264 Elsevier COX-2 Elsevier TPA Elsevier COX-1 Elsevier SGC-7901 Elsevier MCF-7 Elsevier A-549 Elsevier HCT-116 Elsevier L929sA Elsevier G1 Elsevier IKKβ Elsevier IC50 Elsevier LPS Elsevier MBC Elsevier U937 Elsevier HeLa Elsevier MSSA Elsevier CC50 Elsevier Nrf2 Elsevier KB Elsevier L929 Elsevier PPARγ2 Elsevier Capan-2 Elsevier LOVO Elsevier HIV/AIDS Elsevier PGE2 Elsevier Vero Elsevier p47phox Elsevier PMA Elsevier STAT1 Elsevier ATPase Elsevier B16 Elsevier IKK Elsevier SOD Elsevier AKT Elsevier L6 Elsevier AGS Elsevier COX Elsevier PBMCs Elsevier SK-28 Elsevier TNFR1 Elsevier VCAM-1 Elsevier PAF Elsevier TNF-α Elsevier DNA Elsevier PDGF Elsevier SCF Elsevier HepG-2 Elsevier MGC-803 Elsevier sPLA2 Elsevier CVB3 Elsevier PC-3 Elsevier ABTS Elsevier Grigore, Alice oth Pinto, Diana C.G.A. oth Silva, Artur M.S. oth Enthalten in Elsevier Degli Esposti, Sara ELSEVIER Oocyte provision as a (quasi) social market: Insights from Spain 2019 an interdisciplinary journal devoted to bioscientific research on indigenous drugs : the official journal of the International Society of Ethnopharmacology New York, NY [u.a.] (DE-627)ELV002571021 volume:154 year:2014 number:2 day:11 month:06 pages:286-310 extent:25 https://doi.org/10.1016/j.jep.2014.04.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.06 Medizinsoziologie VZ AR 154 2014 2 11 0611 286-310 25 045F 610 |
| spelling |
10.1016/j.jep.2014.04.010 doi GBVA2014013000001.pica (DE-627)ELV017565642 (ELSEVIER)S0378-8741(14)00285-2 DE-627 ger DE-627 rakwb eng 610 390 610 DE-600 390 DE-600 300 610 VZ 44.06 bkl Seca, Ana M.L. verfasserin aut The genus Inula and their metabolites: From ethnopharmacological to medicinal uses 2014transfer abstract 25 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored. The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored. MDA-MB-435 Elsevier JNK Elsevier PMNs Elsevier ICAM-1 Elsevier AHR Elsevier OPN Elsevier NF-κB Elsevier HSV-1 Elsevier PI3K Elsevier MRSA Elsevier iNOS Elsevier LTB4 Elsevier MDCK Elsevier c-FLIP Elsevier ED50 Elsevier Th2 Elsevier QR Elsevier L-NAME Elsevier VSMCs Elsevier HSP70 Elsevier DPPH Elsevier GMK Elsevier MIC Elsevier G2/M Elsevier PLA2 Elsevier SiHa Elsevier SW620 Elsevier GSTs Elsevier IL-2 Elsevier DOX Elsevier HT-29 Elsevier NCI Elsevier Tyrp1 Elsevier ROS Elsevier AMPK Elsevier HL-60 Elsevier MMP-9 Elsevier Bcl-2 Elsevier HIV-1 Elsevier RAW264 Elsevier COX-2 Elsevier TPA Elsevier COX-1 Elsevier SGC-7901 Elsevier MCF-7 Elsevier A-549 Elsevier HCT-116 Elsevier L929sA Elsevier G1 Elsevier IKKβ Elsevier IC50 Elsevier LPS Elsevier MBC Elsevier U937 Elsevier HeLa Elsevier MSSA Elsevier CC50 Elsevier Nrf2 Elsevier KB Elsevier L929 Elsevier PPARγ2 Elsevier Capan-2 Elsevier LOVO Elsevier HIV/AIDS Elsevier PGE2 Elsevier Vero Elsevier p47phox Elsevier PMA Elsevier STAT1 Elsevier ATPase Elsevier B16 Elsevier IKK Elsevier SOD Elsevier AKT Elsevier L6 Elsevier AGS Elsevier COX Elsevier PBMCs Elsevier SK-28 Elsevier TNFR1 Elsevier VCAM-1 Elsevier PAF Elsevier TNF-α Elsevier DNA Elsevier PDGF Elsevier SCF Elsevier HepG-2 Elsevier MGC-803 Elsevier sPLA2 Elsevier CVB3 Elsevier PC-3 Elsevier ABTS Elsevier Grigore, Alice oth Pinto, Diana C.G.A. oth Silva, Artur M.S. oth Enthalten in Elsevier Degli Esposti, Sara ELSEVIER Oocyte provision as a (quasi) social market: Insights from Spain 2019 an interdisciplinary journal devoted to bioscientific research on indigenous drugs : the official journal of the International Society of Ethnopharmacology New York, NY [u.a.] (DE-627)ELV002571021 volume:154 year:2014 number:2 day:11 month:06 pages:286-310 extent:25 https://doi.org/10.1016/j.jep.2014.04.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.06 Medizinsoziologie VZ AR 154 2014 2 11 0611 286-310 25 045F 610 |
| allfields_unstemmed |
10.1016/j.jep.2014.04.010 doi GBVA2014013000001.pica (DE-627)ELV017565642 (ELSEVIER)S0378-8741(14)00285-2 DE-627 ger DE-627 rakwb eng 610 390 610 DE-600 390 DE-600 300 610 VZ 44.06 bkl Seca, Ana M.L. verfasserin aut The genus Inula and their metabolites: From ethnopharmacological to medicinal uses 2014transfer abstract 25 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored. The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored. MDA-MB-435 Elsevier JNK Elsevier PMNs Elsevier ICAM-1 Elsevier AHR Elsevier OPN Elsevier NF-κB Elsevier HSV-1 Elsevier PI3K Elsevier MRSA Elsevier iNOS Elsevier LTB4 Elsevier MDCK Elsevier c-FLIP Elsevier ED50 Elsevier Th2 Elsevier QR Elsevier L-NAME Elsevier VSMCs Elsevier HSP70 Elsevier DPPH Elsevier GMK Elsevier MIC Elsevier G2/M Elsevier PLA2 Elsevier SiHa Elsevier SW620 Elsevier GSTs Elsevier IL-2 Elsevier DOX Elsevier HT-29 Elsevier NCI Elsevier Tyrp1 Elsevier ROS Elsevier AMPK Elsevier HL-60 Elsevier MMP-9 Elsevier Bcl-2 Elsevier HIV-1 Elsevier RAW264 Elsevier COX-2 Elsevier TPA Elsevier COX-1 Elsevier SGC-7901 Elsevier MCF-7 Elsevier A-549 Elsevier HCT-116 Elsevier L929sA Elsevier G1 Elsevier IKKβ Elsevier IC50 Elsevier LPS Elsevier MBC Elsevier U937 Elsevier HeLa Elsevier MSSA Elsevier CC50 Elsevier Nrf2 Elsevier KB Elsevier L929 Elsevier PPARγ2 Elsevier Capan-2 Elsevier LOVO Elsevier HIV/AIDS Elsevier PGE2 Elsevier Vero Elsevier p47phox Elsevier PMA Elsevier STAT1 Elsevier ATPase Elsevier B16 Elsevier IKK Elsevier SOD Elsevier AKT Elsevier L6 Elsevier AGS Elsevier COX Elsevier PBMCs Elsevier SK-28 Elsevier TNFR1 Elsevier VCAM-1 Elsevier PAF Elsevier TNF-α Elsevier DNA Elsevier PDGF Elsevier SCF Elsevier HepG-2 Elsevier MGC-803 Elsevier sPLA2 Elsevier CVB3 Elsevier PC-3 Elsevier ABTS Elsevier Grigore, Alice oth Pinto, Diana C.G.A. oth Silva, Artur M.S. oth Enthalten in Elsevier Degli Esposti, Sara ELSEVIER Oocyte provision as a (quasi) social market: Insights from Spain 2019 an interdisciplinary journal devoted to bioscientific research on indigenous drugs : the official journal of the International Society of Ethnopharmacology New York, NY [u.a.] (DE-627)ELV002571021 volume:154 year:2014 number:2 day:11 month:06 pages:286-310 extent:25 https://doi.org/10.1016/j.jep.2014.04.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.06 Medizinsoziologie VZ AR 154 2014 2 11 0611 286-310 25 045F 610 |
| allfieldsGer |
10.1016/j.jep.2014.04.010 doi GBVA2014013000001.pica (DE-627)ELV017565642 (ELSEVIER)S0378-8741(14)00285-2 DE-627 ger DE-627 rakwb eng 610 390 610 DE-600 390 DE-600 300 610 VZ 44.06 bkl Seca, Ana M.L. verfasserin aut The genus Inula and their metabolites: From ethnopharmacological to medicinal uses 2014transfer abstract 25 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored. The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored. MDA-MB-435 Elsevier JNK Elsevier PMNs Elsevier ICAM-1 Elsevier AHR Elsevier OPN Elsevier NF-κB Elsevier HSV-1 Elsevier PI3K Elsevier MRSA Elsevier iNOS Elsevier LTB4 Elsevier MDCK Elsevier c-FLIP Elsevier ED50 Elsevier Th2 Elsevier QR Elsevier L-NAME Elsevier VSMCs Elsevier HSP70 Elsevier DPPH Elsevier GMK Elsevier MIC Elsevier G2/M Elsevier PLA2 Elsevier SiHa Elsevier SW620 Elsevier GSTs Elsevier IL-2 Elsevier DOX Elsevier HT-29 Elsevier NCI Elsevier Tyrp1 Elsevier ROS Elsevier AMPK Elsevier HL-60 Elsevier MMP-9 Elsevier Bcl-2 Elsevier HIV-1 Elsevier RAW264 Elsevier COX-2 Elsevier TPA Elsevier COX-1 Elsevier SGC-7901 Elsevier MCF-7 Elsevier A-549 Elsevier HCT-116 Elsevier L929sA Elsevier G1 Elsevier IKKβ Elsevier IC50 Elsevier LPS Elsevier MBC Elsevier U937 Elsevier HeLa Elsevier MSSA Elsevier CC50 Elsevier Nrf2 Elsevier KB Elsevier L929 Elsevier PPARγ2 Elsevier Capan-2 Elsevier LOVO Elsevier HIV/AIDS Elsevier PGE2 Elsevier Vero Elsevier p47phox Elsevier PMA Elsevier STAT1 Elsevier ATPase Elsevier B16 Elsevier IKK Elsevier SOD Elsevier AKT Elsevier L6 Elsevier AGS Elsevier COX Elsevier PBMCs Elsevier SK-28 Elsevier TNFR1 Elsevier VCAM-1 Elsevier PAF Elsevier TNF-α Elsevier DNA Elsevier PDGF Elsevier SCF Elsevier HepG-2 Elsevier MGC-803 Elsevier sPLA2 Elsevier CVB3 Elsevier PC-3 Elsevier ABTS Elsevier Grigore, Alice oth Pinto, Diana C.G.A. oth Silva, Artur M.S. oth Enthalten in Elsevier Degli Esposti, Sara ELSEVIER Oocyte provision as a (quasi) social market: Insights from Spain 2019 an interdisciplinary journal devoted to bioscientific research on indigenous drugs : the official journal of the International Society of Ethnopharmacology New York, NY [u.a.] (DE-627)ELV002571021 volume:154 year:2014 number:2 day:11 month:06 pages:286-310 extent:25 https://doi.org/10.1016/j.jep.2014.04.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.06 Medizinsoziologie VZ AR 154 2014 2 11 0611 286-310 25 045F 610 |
| allfieldsSound |
10.1016/j.jep.2014.04.010 doi GBVA2014013000001.pica (DE-627)ELV017565642 (ELSEVIER)S0378-8741(14)00285-2 DE-627 ger DE-627 rakwb eng 610 390 610 DE-600 390 DE-600 300 610 VZ 44.06 bkl Seca, Ana M.L. verfasserin aut The genus Inula and their metabolites: From ethnopharmacological to medicinal uses 2014transfer abstract 25 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored. The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored. MDA-MB-435 Elsevier JNK Elsevier PMNs Elsevier ICAM-1 Elsevier AHR Elsevier OPN Elsevier NF-κB Elsevier HSV-1 Elsevier PI3K Elsevier MRSA Elsevier iNOS Elsevier LTB4 Elsevier MDCK Elsevier c-FLIP Elsevier ED50 Elsevier Th2 Elsevier QR Elsevier L-NAME Elsevier VSMCs Elsevier HSP70 Elsevier DPPH Elsevier GMK Elsevier MIC Elsevier G2/M Elsevier PLA2 Elsevier SiHa Elsevier SW620 Elsevier GSTs Elsevier IL-2 Elsevier DOX Elsevier HT-29 Elsevier NCI Elsevier Tyrp1 Elsevier ROS Elsevier AMPK Elsevier HL-60 Elsevier MMP-9 Elsevier Bcl-2 Elsevier HIV-1 Elsevier RAW264 Elsevier COX-2 Elsevier TPA Elsevier COX-1 Elsevier SGC-7901 Elsevier MCF-7 Elsevier A-549 Elsevier HCT-116 Elsevier L929sA Elsevier G1 Elsevier IKKβ Elsevier IC50 Elsevier LPS Elsevier MBC Elsevier U937 Elsevier HeLa Elsevier MSSA Elsevier CC50 Elsevier Nrf2 Elsevier KB Elsevier L929 Elsevier PPARγ2 Elsevier Capan-2 Elsevier LOVO Elsevier HIV/AIDS Elsevier PGE2 Elsevier Vero Elsevier p47phox Elsevier PMA Elsevier STAT1 Elsevier ATPase Elsevier B16 Elsevier IKK Elsevier SOD Elsevier AKT Elsevier L6 Elsevier AGS Elsevier COX Elsevier PBMCs Elsevier SK-28 Elsevier TNFR1 Elsevier VCAM-1 Elsevier PAF Elsevier TNF-α Elsevier DNA Elsevier PDGF Elsevier SCF Elsevier HepG-2 Elsevier MGC-803 Elsevier sPLA2 Elsevier CVB3 Elsevier PC-3 Elsevier ABTS Elsevier Grigore, Alice oth Pinto, Diana C.G.A. oth Silva, Artur M.S. oth Enthalten in Elsevier Degli Esposti, Sara ELSEVIER Oocyte provision as a (quasi) social market: Insights from Spain 2019 an interdisciplinary journal devoted to bioscientific research on indigenous drugs : the official journal of the International Society of Ethnopharmacology New York, NY [u.a.] (DE-627)ELV002571021 volume:154 year:2014 number:2 day:11 month:06 pages:286-310 extent:25 https://doi.org/10.1016/j.jep.2014.04.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.06 Medizinsoziologie VZ AR 154 2014 2 11 0611 286-310 25 045F 610 |
| language |
English |
| source |
Enthalten in Oocyte provision as a (quasi) social market: Insights from Spain New York, NY [u.a.] volume:154 year:2014 number:2 day:11 month:06 pages:286-310 extent:25 |
| sourceStr |
Enthalten in Oocyte provision as a (quasi) social market: Insights from Spain New York, NY [u.a.] volume:154 year:2014 number:2 day:11 month:06 pages:286-310 extent:25 |
| format_phy_str_mv |
Article |
| bklname |
Medizinsoziologie |
| institution |
findex.gbv.de |
| topic_facet |
MDA-MB-435 JNK PMNs ICAM-1 AHR OPN NF-κB HSV-1 PI3K MRSA iNOS LTB4 MDCK c-FLIP ED50 Th2 QR L-NAME VSMCs HSP70 DPPH GMK MIC G2/M PLA2 SiHa SW620 GSTs IL-2 DOX HT-29 NCI Tyrp1 ROS AMPK HL-60 MMP-9 Bcl-2 HIV-1 RAW264 COX-2 TPA COX-1 SGC-7901 MCF-7 A-549 HCT-116 L929sA G1 IKKβ IC50 LPS MBC U937 HeLa MSSA CC50 Nrf2 KB L929 PPARγ2 Capan-2 LOVO HIV/AIDS PGE2 Vero p47phox PMA STAT1 ATPase B16 IKK SOD AKT L6 AGS COX PBMCs SK-28 TNFR1 VCAM-1 PAF TNF-α DNA PDGF SCF HepG-2 MGC-803 sPLA2 CVB3 PC-3 ABTS |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Oocyte provision as a (quasi) social market: Insights from Spain |
| authorswithroles_txt_mv |
Seca, Ana M.L. @@aut@@ Grigore, Alice @@oth@@ Pinto, Diana C.G.A. @@oth@@ Silva, Artur M.S. @@oth@@ |
| publishDateDaySort_date |
2014-01-11T00:00:00Z |
| hierarchy_top_id |
ELV002571021 |
| dewey-sort |
3610 |
| id |
ELV017565642 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV017565642</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625122456.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jep.2014.04.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014013000001.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV017565642</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-8741(14)00285-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield><subfield code="a">390</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">390</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">300</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.06</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Seca, Ana M.L.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The genus Inula and their metabolites: From ethnopharmacological to medicinal uses</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">25</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MDA-MB-435</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">JNK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PMNs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ICAM-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AHR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">OPN</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NF-κB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HSV-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PI3K</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MRSA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">iNOS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LTB4</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MDCK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">c-FLIP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ED50</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Th2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">QR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">L-NAME</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VSMCs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HSP70</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DPPH</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GMK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MIC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">G2/M</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PLA2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SiHa</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SW620</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GSTs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IL-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DOX</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HT-29</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NCI</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tyrp1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ROS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AMPK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HL-60</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MMP-9</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bcl-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HIV-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RAW264</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">COX-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TPA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">COX-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SGC-7901</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MCF-7</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">A-549</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HCT-116</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">L929sA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">G1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IKKβ</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IC50</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LPS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MBC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">U937</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HeLa</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MSSA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CC50</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nrf2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">KB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">L929</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PPARγ2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Capan-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LOVO</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HIV/AIDS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PGE2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vero</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">p47phox</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PMA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">STAT1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ATPase</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">B16</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IKK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SOD</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AKT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">L6</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AGS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">COX</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PBMCs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SK-28</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TNFR1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VCAM-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PAF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TNF-α</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DNA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PDGF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SCF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HepG-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MGC-803</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">sPLA2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CVB3</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PC-3</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ABTS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grigore, Alice</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pinto, Diana C.G.A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Silva, Artur M.S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Degli Esposti, Sara ELSEVIER</subfield><subfield code="t">Oocyte provision as a (quasi) social market: Insights from Spain</subfield><subfield code="d">2019</subfield><subfield code="d">an interdisciplinary journal devoted to bioscientific research on indigenous drugs : the official journal of the International Society of Ethnopharmacology</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV002571021</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:154</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:2</subfield><subfield code="g">day:11</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:286-310</subfield><subfield code="g">extent:25</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jep.2014.04.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.06</subfield><subfield code="j">Medizinsoziologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">154</subfield><subfield code="j">2014</subfield><subfield code="e">2</subfield><subfield code="b">11</subfield><subfield code="c">0611</subfield><subfield code="h">286-310</subfield><subfield code="g">25</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Seca, Ana M.L. |
| spellingShingle |
Seca, Ana M.L. ddc 610 ddc 390 ddc 300 bkl 44.06 Elsevier MDA-MB-435 Elsevier JNK Elsevier PMNs Elsevier ICAM-1 Elsevier AHR Elsevier OPN Elsevier NF-κB Elsevier HSV-1 Elsevier PI3K Elsevier MRSA Elsevier iNOS Elsevier LTB4 Elsevier MDCK Elsevier c-FLIP Elsevier ED50 Elsevier Th2 Elsevier QR Elsevier L-NAME Elsevier VSMCs Elsevier HSP70 Elsevier DPPH Elsevier GMK Elsevier MIC Elsevier G2/M Elsevier PLA2 Elsevier SiHa Elsevier SW620 Elsevier GSTs Elsevier IL-2 Elsevier DOX Elsevier HT-29 Elsevier NCI Elsevier Tyrp1 Elsevier ROS Elsevier AMPK Elsevier HL-60 Elsevier MMP-9 Elsevier Bcl-2 Elsevier HIV-1 Elsevier RAW264 Elsevier COX-2 Elsevier TPA Elsevier COX-1 Elsevier SGC-7901 Elsevier MCF-7 Elsevier A-549 Elsevier HCT-116 Elsevier L929sA Elsevier G1 Elsevier IKKβ Elsevier IC50 Elsevier LPS Elsevier MBC Elsevier U937 Elsevier HeLa Elsevier MSSA Elsevier CC50 Elsevier Nrf2 Elsevier KB Elsevier L929 Elsevier PPARγ2 Elsevier Capan-2 Elsevier LOVO Elsevier HIV/AIDS Elsevier PGE2 Elsevier Vero Elsevier p47phox Elsevier PMA Elsevier STAT1 Elsevier ATPase Elsevier B16 Elsevier IKK Elsevier SOD Elsevier AKT Elsevier L6 Elsevier AGS Elsevier COX Elsevier PBMCs Elsevier SK-28 Elsevier TNFR1 Elsevier VCAM-1 Elsevier PAF Elsevier TNF-α Elsevier DNA Elsevier PDGF Elsevier SCF Elsevier HepG-2 Elsevier MGC-803 Elsevier sPLA2 Elsevier CVB3 Elsevier PC-3 Elsevier ABTS The genus Inula and their metabolites: From ethnopharmacological to medicinal uses |
| authorStr |
Seca, Ana M.L. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV002571021 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 390 - Customs, etiquette & folklore 300 - Social sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 390 610 DE-600 390 DE-600 300 610 VZ 44.06 bkl The genus Inula and their metabolites: From ethnopharmacological to medicinal uses MDA-MB-435 Elsevier JNK Elsevier PMNs Elsevier ICAM-1 Elsevier AHR Elsevier OPN Elsevier NF-κB Elsevier HSV-1 Elsevier PI3K Elsevier MRSA Elsevier iNOS Elsevier LTB4 Elsevier MDCK Elsevier c-FLIP Elsevier ED50 Elsevier Th2 Elsevier QR Elsevier L-NAME Elsevier VSMCs Elsevier HSP70 Elsevier DPPH Elsevier GMK Elsevier MIC Elsevier G2/M Elsevier PLA2 Elsevier SiHa Elsevier SW620 Elsevier GSTs Elsevier IL-2 Elsevier DOX Elsevier HT-29 Elsevier NCI Elsevier Tyrp1 Elsevier ROS Elsevier AMPK Elsevier HL-60 Elsevier MMP-9 Elsevier Bcl-2 Elsevier HIV-1 Elsevier RAW264 Elsevier COX-2 Elsevier TPA Elsevier COX-1 Elsevier SGC-7901 Elsevier MCF-7 Elsevier A-549 Elsevier HCT-116 Elsevier L929sA Elsevier G1 Elsevier IKKβ Elsevier IC50 Elsevier LPS Elsevier MBC Elsevier U937 Elsevier HeLa Elsevier MSSA Elsevier CC50 Elsevier Nrf2 Elsevier KB Elsevier L929 Elsevier PPARγ2 Elsevier Capan-2 Elsevier LOVO Elsevier HIV/AIDS Elsevier PGE2 Elsevier Vero Elsevier p47phox Elsevier PMA Elsevier STAT1 Elsevier ATPase Elsevier B16 Elsevier IKK Elsevier SOD Elsevier AKT Elsevier L6 Elsevier AGS Elsevier COX Elsevier PBMCs Elsevier SK-28 Elsevier TNFR1 Elsevier VCAM-1 Elsevier PAF Elsevier TNF-α Elsevier DNA Elsevier PDGF Elsevier SCF Elsevier HepG-2 Elsevier MGC-803 Elsevier sPLA2 Elsevier CVB3 Elsevier PC-3 Elsevier ABTS Elsevier |
| topic |
ddc 610 ddc 390 ddc 300 bkl 44.06 Elsevier MDA-MB-435 Elsevier JNK Elsevier PMNs Elsevier ICAM-1 Elsevier AHR Elsevier OPN Elsevier NF-κB Elsevier HSV-1 Elsevier PI3K Elsevier MRSA Elsevier iNOS Elsevier LTB4 Elsevier MDCK Elsevier c-FLIP Elsevier ED50 Elsevier Th2 Elsevier QR Elsevier L-NAME Elsevier VSMCs Elsevier HSP70 Elsevier DPPH Elsevier GMK Elsevier MIC Elsevier G2/M Elsevier PLA2 Elsevier SiHa Elsevier SW620 Elsevier GSTs Elsevier IL-2 Elsevier DOX Elsevier HT-29 Elsevier NCI Elsevier Tyrp1 Elsevier ROS Elsevier AMPK Elsevier HL-60 Elsevier MMP-9 Elsevier Bcl-2 Elsevier HIV-1 Elsevier RAW264 Elsevier COX-2 Elsevier TPA Elsevier COX-1 Elsevier SGC-7901 Elsevier MCF-7 Elsevier A-549 Elsevier HCT-116 Elsevier L929sA Elsevier G1 Elsevier IKKβ Elsevier IC50 Elsevier LPS Elsevier MBC Elsevier U937 Elsevier HeLa Elsevier MSSA Elsevier CC50 Elsevier Nrf2 Elsevier KB Elsevier L929 Elsevier PPARγ2 Elsevier Capan-2 Elsevier LOVO Elsevier HIV/AIDS Elsevier PGE2 Elsevier Vero Elsevier p47phox Elsevier PMA Elsevier STAT1 Elsevier ATPase Elsevier B16 Elsevier IKK Elsevier SOD Elsevier AKT Elsevier L6 Elsevier AGS Elsevier COX Elsevier PBMCs Elsevier SK-28 Elsevier TNFR1 Elsevier VCAM-1 Elsevier PAF Elsevier TNF-α Elsevier DNA Elsevier PDGF Elsevier SCF Elsevier HepG-2 Elsevier MGC-803 Elsevier sPLA2 Elsevier CVB3 Elsevier PC-3 Elsevier ABTS |
| topic_unstemmed |
ddc 610 ddc 390 ddc 300 bkl 44.06 Elsevier MDA-MB-435 Elsevier JNK Elsevier PMNs Elsevier ICAM-1 Elsevier AHR Elsevier OPN Elsevier NF-κB Elsevier HSV-1 Elsevier PI3K Elsevier MRSA Elsevier iNOS Elsevier LTB4 Elsevier MDCK Elsevier c-FLIP Elsevier ED50 Elsevier Th2 Elsevier QR Elsevier L-NAME Elsevier VSMCs Elsevier HSP70 Elsevier DPPH Elsevier GMK Elsevier MIC Elsevier G2/M Elsevier PLA2 Elsevier SiHa Elsevier SW620 Elsevier GSTs Elsevier IL-2 Elsevier DOX Elsevier HT-29 Elsevier NCI Elsevier Tyrp1 Elsevier ROS Elsevier AMPK Elsevier HL-60 Elsevier MMP-9 Elsevier Bcl-2 Elsevier HIV-1 Elsevier RAW264 Elsevier COX-2 Elsevier TPA Elsevier COX-1 Elsevier SGC-7901 Elsevier MCF-7 Elsevier A-549 Elsevier HCT-116 Elsevier L929sA Elsevier G1 Elsevier IKKβ Elsevier IC50 Elsevier LPS Elsevier MBC Elsevier U937 Elsevier HeLa Elsevier MSSA Elsevier CC50 Elsevier Nrf2 Elsevier KB Elsevier L929 Elsevier PPARγ2 Elsevier Capan-2 Elsevier LOVO Elsevier HIV/AIDS Elsevier PGE2 Elsevier Vero Elsevier p47phox Elsevier PMA Elsevier STAT1 Elsevier ATPase Elsevier B16 Elsevier IKK Elsevier SOD Elsevier AKT Elsevier L6 Elsevier AGS Elsevier COX Elsevier PBMCs Elsevier SK-28 Elsevier TNFR1 Elsevier VCAM-1 Elsevier PAF Elsevier TNF-α Elsevier DNA Elsevier PDGF Elsevier SCF Elsevier HepG-2 Elsevier MGC-803 Elsevier sPLA2 Elsevier CVB3 Elsevier PC-3 Elsevier ABTS |
| topic_browse |
ddc 610 ddc 390 ddc 300 bkl 44.06 Elsevier MDA-MB-435 Elsevier JNK Elsevier PMNs Elsevier ICAM-1 Elsevier AHR Elsevier OPN Elsevier NF-κB Elsevier HSV-1 Elsevier PI3K Elsevier MRSA Elsevier iNOS Elsevier LTB4 Elsevier MDCK Elsevier c-FLIP Elsevier ED50 Elsevier Th2 Elsevier QR Elsevier L-NAME Elsevier VSMCs Elsevier HSP70 Elsevier DPPH Elsevier GMK Elsevier MIC Elsevier G2/M Elsevier PLA2 Elsevier SiHa Elsevier SW620 Elsevier GSTs Elsevier IL-2 Elsevier DOX Elsevier HT-29 Elsevier NCI Elsevier Tyrp1 Elsevier ROS Elsevier AMPK Elsevier HL-60 Elsevier MMP-9 Elsevier Bcl-2 Elsevier HIV-1 Elsevier RAW264 Elsevier COX-2 Elsevier TPA Elsevier COX-1 Elsevier SGC-7901 Elsevier MCF-7 Elsevier A-549 Elsevier HCT-116 Elsevier L929sA Elsevier G1 Elsevier IKKβ Elsevier IC50 Elsevier LPS Elsevier MBC Elsevier U937 Elsevier HeLa Elsevier MSSA Elsevier CC50 Elsevier Nrf2 Elsevier KB Elsevier L929 Elsevier PPARγ2 Elsevier Capan-2 Elsevier LOVO Elsevier HIV/AIDS Elsevier PGE2 Elsevier Vero Elsevier p47phox Elsevier PMA Elsevier STAT1 Elsevier ATPase Elsevier B16 Elsevier IKK Elsevier SOD Elsevier AKT Elsevier L6 Elsevier AGS Elsevier COX Elsevier PBMCs Elsevier SK-28 Elsevier TNFR1 Elsevier VCAM-1 Elsevier PAF Elsevier TNF-α Elsevier DNA Elsevier PDGF Elsevier SCF Elsevier HepG-2 Elsevier MGC-803 Elsevier sPLA2 Elsevier CVB3 Elsevier PC-3 Elsevier ABTS |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a g ag d c p dc dcp a m s am ams |
| hierarchy_parent_title |
Oocyte provision as a (quasi) social market: Insights from Spain |
| hierarchy_parent_id |
ELV002571021 |
| dewey-tens |
610 - Medicine & health 390 - Customs, etiquette & folklore 300 - Social sciences, sociology & anthropology |
| hierarchy_top_title |
Oocyte provision as a (quasi) social market: Insights from Spain |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV002571021 |
| title |
The genus Inula and their metabolites: From ethnopharmacological to medicinal uses |
| ctrlnum |
(DE-627)ELV017565642 (ELSEVIER)S0378-8741(14)00285-2 |
| title_full |
The genus Inula and their metabolites: From ethnopharmacological to medicinal uses |
| author_sort |
Seca, Ana M.L. |
| journal |
Oocyte provision as a (quasi) social market: Insights from Spain |
| journalStr |
Oocyte provision as a (quasi) social market: Insights from Spain |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 300 - Social sciences |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
286 |
| author_browse |
Seca, Ana M.L. |
| container_volume |
154 |
| physical |
25 |
| class |
610 390 610 DE-600 390 DE-600 300 610 VZ 44.06 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Seca, Ana M.L. |
| doi_str_mv |
10.1016/j.jep.2014.04.010 |
| dewey-full |
610 390 300 |
| title_sort |
genus inula and their metabolites: from ethnopharmacological to medicinal uses |
| title_auth |
The genus Inula and their metabolites: From ethnopharmacological to medicinal uses |
| abstract |
The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored. |
| abstractGer |
The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored. |
| abstract_unstemmed |
The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
2 |
| title_short |
The genus Inula and their metabolites: From ethnopharmacological to medicinal uses |
| url |
https://doi.org/10.1016/j.jep.2014.04.010 |
| remote_bool |
true |
| author2 |
Grigore, Alice Pinto, Diana C.G.A. Silva, Artur M.S. |
| author2Str |
Grigore, Alice Pinto, Diana C.G.A. Silva, Artur M.S. |
| ppnlink |
ELV002571021 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth |
| doi_str |
10.1016/j.jep.2014.04.010 |
| up_date |
2024-07-06T16:39:01.504Z |
| _version_ |
1803848454252789760 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV017565642</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625122456.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jep.2014.04.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014013000001.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV017565642</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-8741(14)00285-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield><subfield code="a">390</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">390</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">300</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.06</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Seca, Ana M.L.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The genus Inula and their metabolites: From ethnopharmacological to medicinal uses</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">25</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MDA-MB-435</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">JNK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PMNs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ICAM-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AHR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">OPN</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NF-κB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HSV-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PI3K</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MRSA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">iNOS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LTB4</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MDCK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">c-FLIP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ED50</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Th2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">QR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">L-NAME</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VSMCs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HSP70</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DPPH</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GMK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MIC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">G2/M</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PLA2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SiHa</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SW620</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GSTs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IL-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DOX</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HT-29</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NCI</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tyrp1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ROS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AMPK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HL-60</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MMP-9</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bcl-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HIV-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RAW264</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">COX-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TPA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">COX-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SGC-7901</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MCF-7</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">A-549</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HCT-116</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">L929sA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">G1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IKKβ</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IC50</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LPS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MBC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">U937</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HeLa</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MSSA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CC50</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nrf2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">KB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">L929</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PPARγ2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Capan-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LOVO</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HIV/AIDS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PGE2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vero</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">p47phox</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PMA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">STAT1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ATPase</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">B16</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IKK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SOD</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AKT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">L6</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AGS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">COX</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PBMCs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SK-28</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TNFR1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VCAM-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PAF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TNF-α</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DNA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PDGF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SCF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HepG-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MGC-803</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">sPLA2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CVB3</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PC-3</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ABTS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grigore, Alice</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pinto, Diana C.G.A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Silva, Artur M.S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Degli Esposti, Sara ELSEVIER</subfield><subfield code="t">Oocyte provision as a (quasi) social market: Insights from Spain</subfield><subfield code="d">2019</subfield><subfield code="d">an interdisciplinary journal devoted to bioscientific research on indigenous drugs : the official journal of the International Society of Ethnopharmacology</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV002571021</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:154</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:2</subfield><subfield code="g">day:11</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:286-310</subfield><subfield code="g">extent:25</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jep.2014.04.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.06</subfield><subfield code="j">Medizinsoziologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">154</subfield><subfield code="j">2014</subfield><subfield code="e">2</subfield><subfield code="b">11</subfield><subfield code="c">0611</subfield><subfield code="h">286-310</subfield><subfield code="g">25</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.3998213 |